Share the post "Mutual Fund Data: Stock Market Insights on – 26 Sep -Amrutanjan Health Care"
Company Logo | Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
---|---|---|---|---|---|---|
Gulf Oil Lubricants India | Aditya Birla Sun Life Insurance Company | Buy | 925K | 1351.00 | Gulf Oil International Mauritius Inc | |
Iti Mutual Fund | Buy | 296K | 1351.00 | Gulf Oil International Mauritius Inc | ||
Amrutanjan Health Care | Icici Prudential Mutual Fund | Buy | 650K | 760.00 | Nageswaramma Private Trust |
The 925K shares of Gulf Oil Lubricants India have been purchased by the by Aditya Birla Sun Life Insurance Company through mutual funds at a price of ₹1351.00 per shareand it is sold by Gulf Oil International Mauritius Inc at a price of ₹1351.00 per share.
The 650K shares of Amrutanjan Health Care have been purchased by the by Icici Prudential Mutual Fund through mutual funds at a price of ₹760.00 per shareand it is sold by Nageswaramma Private Trust at a price of ₹760.00 per share.
The 296K shares of Gulf Oil Lubricants India have been purchased by the by Iti Mutual Fund through mutual funds at a price of ₹1351.00 per shareand it is sold by Gulf Oil International Mauritius Inc at a price of ₹1351.00 per share.
Company Logo | Company | Client Name | Buy/Sell | Qty Traded | Price | Trader Name |
---|---|---|---|---|---|---|
Gulf Oil Lubricants India | Aditya Birla Sun Life Insurance Company | Buy | 925K | 1351 | Gulf Oil International Mauritius Inc | |
Iti Mutual Fund | Buy | 296K | 1351 | Gulf Oil International Mauritius Inc | ||
Jm Financial Mutual Fund | Buy | 148K | 1351 | Gulf Oil International Mauritius Inc | ||
Uti Mutual Fund | Buy | 78K | 1351 | Gulf Oil International Mauritius Inc | ||
Five-star Business Finance | Hdfc Mutual Fund | Buy | 834K | 800.5 | Norwest Venture Partners X Mauritius | |
Hdfc Mutual Fund | Buy | 417K | 800.5 | Norwest Venture Partners X Mauritius |
Gulf Oil Lubricants India shares totaling 925K were purchased by the by Aditya Birla Sun Life Insurance Company of MutualFund, with the transaction occurring at a price of ₹1351 per share. Subsequently, the shares were sold by Gulf Oil International Mauritius Inc at the same price per share.Five-star Business Finance shares totaling 834K were purchased by the by Hdfc Mutual Fund of MutualFund, with the transaction occurring at a price of ₹800.5 per share. Subsequently, the shares were sold by Norwest Venture Partners X Mauritius at the same price per share.Five-star Business Finance shares totaling 417K were purchased by the by Hdfc Mutual Fund of MutualFund, with the transaction occurring at a price of ₹800.5 per share. Subsequently, the shares were sold by Norwest Venture Partners X Mauritius at the same price per share.
Gulf Oil Lubricants India shares totaling 296K were purchased by the by Iti Mutual Fund of MutualFund, with the transaction occurring at a price of ₹1351 per share. Subsequently, the shares were sold by Gulf Oil International Mauritius Inc at the same price per share.Gulf Oil Lubricants India shares totaling 148K were purchased by the by Jm Financial Mutual Fund of MutualFund, with the transaction occurring at a price of ₹1351 per share. Subsequently, the shares were sold by Gulf Oil International Mauritius Inc at the same price per share.Gulf Oil Lubricants India shares totaling 78K were purchased by the by Uti Mutual Fund of MutualFund, with the transaction occurring at a price of ₹1351 per share. Subsequently, the shares were sold by Gulf Oil International Mauritius Inc at the same price per share.
Gulf Oil Lubricants India Limited
8,850.73
Net Sales
880.23
Net Profit
9,023.59
Total Income
7,841.59
Expenditure
1,397
Current Price
6,878
Market Cap
In the most recent financial analysis for Gulf Oil Lubricants India Limited, key metrics demonstrate a solid performance. The net sales reached ₹8,850.73 million, with total income amounting to ₹9,023.59 million. Expenditure was recorded at ₹7,841.59 million, resulting in a net profit of ₹880.23 million. EPS figures for continuing operations are ₹17.90. Other notable figures include other income of ₹172.86 million, finance costs of ₹45.09 million, and employee benefit expenses totaling ₹407.10 million. Depreciation and amortization expenses were ₹108.21 million, with current tax at ₹311.88 million and deferred tax at ₹-10.10 million. The total comprehensive income for the period was ₹876.29 million, and other comprehensive income net of taxes was ₹-3.94 million.
The company's market cap is ₹6,878 crore, with a stock price of ₹1,397. The historical stock range has been between ₹1,514 / 521. Its Price-to-Earnings (P/E) ratio of 21.3 indicates a high valuation. The book value per share is ₹263, and it has a dividend yield of 2.58%. The ROCE is 26.5% and ROE is 24.7%. With a very low debt-to-equity ratio of 0.28, the company is minimally leveraged. However, it reports a negative net cash flow of ₹52.9 crore. The Piotroski score of 6.00 and the Graham Number of ₹627 show mixed financial indicators, while the Price-to-Book (P/B) ratio of 5.30 suggests the stock is trading at a premium.
Amrutanjan Health Care Limited
0.00
Net Sales
46.16
Net Profit
881.88
Total Income
-818.39
Expenditure
754
Current Price
2,181
Market Cap
In Amrutanjan Health Care Limited's recent financial report, the data highlights a robust performance. Net sales reached ₹0.00 million, with total income of ₹881.88 million. The expenditure was ₹-818.39 million, leading to a net profit of ₹46.16 million. Earnings per Share (EPS) for continuing operations were reported at ₹1.60. The financial overview also includes other income of ₹44.52 million, finance costs of ₹-0.65 million, and employee benefit expenses totaling ₹-138.59 million. Depreciation and amortization expenses were ₹-15.87 million. Current and deferred taxes were recorded at ₹-19.21 million and ₹1.88 million, respectively. The total comprehensive income for the period was ₹0.00 million, and other comprehensive income net of taxes was ₹0.00 million.
The company's market cap is ₹2,181 crore, with a stock price of ₹754. The historical stock range has been between ₹863 / 556. Its Price-to-Earnings (P/E) ratio of 107 indicates a high valuation. The book value per share is ₹37.2, and it has a dividend yield of 0.62%. The ROCE is 31.4% and ROE is 20.0%. With a very low debt-to-equity ratio of 0.02, the company is minimally leveraged. However, it reports a negative net cash flow of ₹11.8 crore. The Piotroski score of 8.00 and the Graham Number of ₹76.8 show mixed financial indicators, while the Price-to-Book (P/B) ratio of 20.2 suggests the stock is trading at a premium.
Five-Star Business Finance Limited
6,661.44
Net Sales
2,515.70
Net Profit
6,693.81
Total Income
3,331.94
Expenditure
785
Current Price
22,958
Market Cap
In the most recent financial analysis for Five-Star Business Finance Limited, key metrics demonstrate a solid performance. The net sales reached ₹6,661.44 million, with total income amounting to ₹6,693.81 million. Expenditure was recorded at ₹3,331.94 million, resulting in a net profit of ₹2,515.70 million. EPS figures for continuing operations are ₹8.60. Other notable figures include other income of ₹32.38 million, finance costs of ₹1,581.90 million, and employee benefit expenses totaling ₹1,228.13 million. Depreciation and amortization expenses were ₹63.75 million, with current tax at ₹918.77 million and deferred tax at ₹-72.60 million. The total comprehensive income for the period was ₹2,510.79 million, and other comprehensive income net of taxes was ₹-4.91 million.
Valued at ₹22,958 crore, the company's stock trades at ₹785, with historical highs and lows of ₹863 / 600. The P/E ratio of 147 reflects a high stock valuation. The book value is ₹, and the dividend yield is 0.00%. ROCE is at 17.0%, and ROE is 16.0%. The company’s minimal debt-to-equity ratio of 0.70 contrasts with its negative net cash flow of ₹88.2 crore. The Piotroski score is 4.00, and the Graham Number of ₹ provides insight into the stock’s valuation. The Price-to-Book (P/B) ratio of indicates a premium valuation.